Mosby's Drug Reference vs IV Medications Elsevier

14-Day Free Trial ** Trusted by Health Care Professionals for Over 30 Years ** ABOUT MOSBY’S DRUG REFERENCE Based on the latest edition, Mosby's Drug Reference provides health care professionals with the tools they need to eliminate errors and improve accuracy. Drug monographs feature concise, easy-to-understand information and make finding answers easy with sections on each drug's action, usage, dosage, interactions, side effects, and more. With an emphasis on patient safety, this best-selling app includes Black Box Warnings for dangerous adverse reactions, Safety Alerts for situations requiring special attention, and a focus on life-threatening side effects of 50 common drug classes. FEATURES • More than 5,000 generic and trade-name drugs are profiled • Appendix of recent FDA-approvals • Icons for High Alert and Rarely Used medications • Highlighted Black Box Warnings, safety alerts, and life-threatening side effects • Helpful IV therapy updates • Create custom notes and highlights within entries • 150+ abbreviations listed for practical understanding • Unlabeled uses and help with easily confused drug names • Full Text Search helps find medications quickly • “Favorites” for bookmarking important entries FREE 14-DAY TRIAL: WHAT TO EXPECT • First-time users can access Unbound's complete Mosby's Drug Reference mobile app free for 14 days • After 14 days, your iTunes account will be charged $45.99 for a one-year subscription unless you have turned off auto-renew at least 24 hours before the free trial ends. • To manage your subscriptions, open Apple's “Settings” app and tap on the “iTunes & App Store" entry. Tap your Apple ID at the top of the screen and login. Tap subscriptions, then tap the subscription you wish to manage. •NOTE: If you choose not to purchase a subscription, content will no longer be viewable after the free trial period. iTunes automatic renewal: Your subscription automatically renews unless auto-renew is turned off 24 hours prior to the conclusion of your current period. Auto Subscriptions may be managed by the user and auto-renewal may be turned off by going to the user's Account Settings after purchase. Your iTunes account will automatically be charged the current renewal rate ($45.99) within 24 hours prior to the end of the subscription period. If you choose not to renew, you will be able to use the app, however will not receive updates. Authors: Linda Skidmore-Roth, RN, MSN, NP Publisher: Elsevier Powered by: Unbound Medicine Unbound Privacy Policy: www.unboundmedicine.com/privacy Unbound Terms of Use: https://www.unboundmedicine.com/end_user_license_agreement

"Try before you buy" - Download the FREE App, which includes sample content. In-App purchase required to unlock all content. For nearly 50 years - #1 IV drug handbook to safely administer more than 400 intravenous drugs! Drug monographs for 10-20 newly approved drugs by the FDA include the most current information Elsevier’s Intravenous Medications: A Handbook for Nurses and Health Professionals has been a trusted resource for complete, accurate drug information in a concise, quick-access format. New to the 2026 edition are many new monographs of the most recent IV drugs to be approved by the FDA, in addition to updated drug uses, interactions, precautions, alerts, and patient teaching instructions for all current IV drugs. Known as the #1 IV drug handbook on the market, this annual publication is ideal for use in critical care areas, at the nursing station, in the office, and in public health and home care settings. New to this edition - New drug monographs for approximately 10-20 newly approved drugs by the FDA provides readers with the most current drug information - Each monograph updated as necessary with new interactions, precautions, alerts, patient teaching instructions, and other need-to-know information. Current information helps nurses feel confident in the accuracy of the information and helps prevent medication dispensing errors Key Features - Annual publication prevents users from referencing outdated information - 40-year history of impeccable accuracy reinforces the importance of safe IV drug administration - Monographs on more than 400 IV drugs offers an impressive breadth of coverage that goes well beyond any comparable drug reference - Proven, clinically-optimized page layout keeps all dosage information for each drug on either a single page or a two-page spread to prevent hand contamination by having to turn a page - Highlighted Black Box Warnings and relevant content make locating critical information fast and easy - Special circumstances in blue-screened text call attention to important circumstances that may not warrant black box warnings - Convenient, alphabetical format organizes all drug monographs by generic name, allowing users to find any drug in seconds - Dilution and dosage charts within monographs provide quick access to essential clinical information - Life stage dosage variances are highlighted for geriatric, pediatric, infant, and neonatal patients Content licensed from printed edition ISBN-10: 0443269599 Content licensed from printed edition ISBN-13: 9780443269592 SUBSCRIPTION : Please purchase a yearly auto-renewing subscription to receive content access and available updates. Yearly auto-renewing payments- $49.99 Payment will be charged to your iTunes Account at confirmation of purchase. Subscription automatically renews unless auto-renew is turned off at least 24-hours before the end of the current period. Subscription may be managed by the user and auto-renewal can be disabled at any time by going to your device “Settings” and tapping “iTunes & App Store”. Any unused portion of a free trial period will be forfeited when you purchase a subscription, where applicable. If you have any questions or comments, email us any time: customersupport@skyscape.com or call 508-299-3000 Privacy Policy - https://www.skyscape.com/terms-of-service/privacypolicy.aspx Terms and Conditions - https://www.skyscape.com/terms-of-service/licenseagreement.aspx Author(s):Shelly Rainforth Collins, PharmD Publisher:Elsevier Health Sciences